Santen Pharmaceutical Co., Ltd.
SNPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $92,997,000 | $94,582,000 | $57,903,000 | $83,014,000 |
| Short-Term Investments | $997,000 | $379,000 | $774,000 | $1,293,000 |
| Receivables | $71,759,000 | $90,539,000 | $107,165,000 | $99,591,000 |
| Inventory | $51,590,000 | $43,185,000 | $39,352,000 | $37,141,000 |
| Other Curr. Assets | $6,957,000 | $7,454,000 | $8,132,000 | $8,387,000 |
| Total Curr. Assets | $224,300,000 | $236,139,000 | $213,326,000 | $229,426,000 |
| Property Plant & Equip (Net) | $72,954,000 | $71,576,000 | $66,173,000 | $56,287,000 |
| Goodwill | $8,242,000 | $8,303,000 | $7,385,000 | $13,715,000 |
| Intangibles | $67,225,000 | $75,516,000 | $88,924,000 | $116,502,000 |
| Long-Term Investments | $26,539,000 | $24,406,000 | $36,585,000 | $40,944,000 |
| Tax Assets | $10,017,000 | $0 | $2,810,000 | $3,103,000 |
| Other NC Assets | $1,000 | $19,759,000 | $5,976,000 | $0 |
| Total NC Assets | $184,978,000 | $199,560,000 | $207,853,000 | $230,551,000 |
| Other Assets | -$1,000 | $0 | $0 | -$1,000 |
| Total Assets | $409,277,000 | $435,699,000 | $421,179,000 | $459,976,000 |
| Liabilities | – | – | – | – |
| Payables | $38,989,000 | $43,531,000 | $44,945,000 | $41,185,000 |
| Short-Term Debt | $3,289,000 | $2,748,000 | $3,056,000 | $13,965,000 |
| Tax Payable | $2,239,000 | $5,127,000 | $6,745,000 | $4,198,000 |
| Deferred Revenue | $0 | $0 | -$3,056,000 | -$13,965,000 |
| Other Curr. Liab. | $42,320,000 | $41,390,000 | $37,814,000 | $50,438,000 |
| Total Curr. Liab. | $86,837,000 | $92,796,000 | $89,504,000 | $95,821,000 |
| LT Debt | $0 | $0 | $28,198,000 | $12,677,000 |
| Deferred Rev, NC | $0 | $738,000 | -$28,198,000 | -$12,677,000 |
| Deferred Tax Liab, NC | $2,606,000 | $1,377,000 | $1,592,000 | $2,526,000 |
| Other NC Liab. | $34,653,000 | $35,419,000 | $36,786,000 | $24,785,000 |
| Total NC Liab. | $37,259,000 | $37,534,000 | $38,378,000 | $27,311,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3,015,000 | $2,694,000 | $2,811,000 | $3,029,000 |
| Total Liabilities | $124,096,000 | $130,330,000 | $127,882,000 | $123,132,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8,806,000 | $8,777,000 | $8,702,000 | $8,672,000 |
| Retained Earnings | $228,291,000 | $240,029,000 | $238,071,000 | $290,477,000 |
| AOCI | $40,509,000 | $48,413,000 | $37,781,000 | $29,686,000 |
| Other Equity | $8,636,000 | $8,836,000 | $9,425,000 | $8,652,000 |
| Total Equity | $286,242,000 | $306,055,000 | $293,979,000 | $337,488,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1,061,000 | -$685,000 | -$683,000 | -$645,000 |
| Total Liab. & Tot. Equity | $409,277,000 | $435,699,000 | $421,861,000 | $460,620,000 |
| Net Debt | -$89,708,000 | -$91,834,000 | -$26,649,000 | -$56,372,000 |